S. Sharif

Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes

A. Algra, H. Nathoe, T. Leiner, 2021, Cardiovascular Diabetology.

Mediation analysis of the relationship between type 2 diabetes and cardiovascular events and all‐cause mortality: Findings from the SMART cohort

Y. van der Graaf, R. Groenwold, F. Visseren, 2019, Diabetes, obesity & metabolism.

Association between bone metabolism regulators and arterial stiffness in type 2 diabetes patients.

M. Bots, C. Stehouwer, C. Schalkwijk, 2018, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Response to Comment on Sharif et al. HDL Cholesterol as a Residual Risk Factor for Vascular Events and All-Cause Mortality in Patients With Type 2 Diabetes. Diabetes Care 2016;39:1424–1430

H. Nathoe, Y. van der Graaf, F. Visseren, 2016, Diabetes Care.

Anesthesia and Arrhythmogenesis in the Chronic Atrioventricular Block Dog Model

M. Vos, M. A. van der Heyden, P. Oosterhoff, 2010, Journal of cardiovascular pharmacology.

Waist to height ratio (0.5) as a predictor for prediabetes and type 2 diabetes in Indonesia

P. Soewondo, Y. Tjang, S. Sharif, 2018, IOP Conference Series: Materials Science and Engineering.

HDL Cholesterol as a Residual Risk Factor for Vascular Events and All-Cause Mortality in Patients With Type 2 Diabetes

H. Nathoe, Y. van der Graaf, F. Visseren, 2016, Diabetes Care.

Arterial stiffness as a risk factor for cardiovascular events and all‐cause mortality in people with Type 2 diabetes

W. Spiering, M. Bots, P. D. de Jong, 2019, Diabetic medicine : a journal of the British Diabetic Association.

Anesthesia and Arrhythmogenesis in the Chronic Atrioventricular Block Dog Model

M. Vos, P. Oosterhoff, R. van der Nagel, 2010, Journal of cardiovascular pharmacology.